2019 Clearinghouse Rule Index

Educational interpreters licensure changes [Admin.Code PI 34.086] - CR 19-111

Sensory impairment terminology and deaf-blindness re education of children [Admin.Code PI 11.03, 11.36] - CR 20-072

Substitute educational interpreter licenses: changes to rules [Admin.Code PI 34.095] - CR 20-024

deer Deer, see Hunting

dentistry Dentistry, see also Medical malpractice

Advance practice nurse prescribers collaboration with dentists [Admin.Code N 8.10] - CR 18-050

Delegation of functions to unlicensed persons [Admin.Code DE 12.01, 12.02, 12.04] - CR 18-063

Dental licensure and the practice of dental hygiene: requirements revised, clarifications, and obsolete provisions repealed [Admin.Code DE 2.01, 2.015, 2.03, 2.04, 2.05, 2.06, 2.07, 2.08, 2.09, 3.02, 3.03, 3.04] - CR 17-068

Dentistry: laboratory work and authorizations, sedation and anesthesia [Admin.Code DE 9.015, 9.02, 11.02, 11.025, 11.03, 11.035, 11.04, 11.05, 11.06, 11.07, 11.075, 11.08, 11.085, 11.09, 11.10] - CR 19-132

Preservation of dental patient health care records [Admin.Code DE 8.035] - CR 18-089

designer Designer, see Architect

detective Detective

Electric weapons: definition and private security credential holders [Admin.Code SPS 30.02, 33.025, 34.065, 34.07, 35.01] - CR 20-021

dfi DFI, see Financial Institutions, Department of

dha DHA, see Hearings and Appeals, Division of

dhs DHS, see health services department of -- specific subheading

dietitian Dietitian, see Medical service — Occupations

disability insurance Disability insurance, see Insurance — Health

disabled persons Disabled persons, see Persons with disabilities

discrimination in employment Discrimination in employment

Discrimination based on arrest or conviction record re issuing or suspending a license [Admin.Code MPSW 3.01, 3.05, 3.07, 3.09, 3.12, 3.13, 11.01, 11.04, 16.01] - CR 19-116

disease Disease, see also Animal — Disease; Vaccination

Absence provisions: temporary care, including child care, for immediate family members [Admin.Code ER 18.01, 18.03] - CR 20-089

Screening of newborns for congenital and metabolic disorders [Admin.Code DHS 115 (title), 115.01, 115.04] - CR 19-064

dnr DNR, see natural resources, department of -- specific subheading

doa DOA, see administration department of -- specific subheading

doc DOC, see Corrections, Department of

dogs Dogs

Dog sellers and dog facility operator licensing requirements [Admin.Code ATCP 16.01, 16.02, 16.04, 16.06, 16.08, 16.14, 16.15, 16.16, 16.18, 16.19, 16.20, 16.22, 16.24, 16.28, 16.30] - CR 18-032

doj DOJ, see Justice, Department of

dor DOR, see Revenue, Department of

dot DOT, see transportation, department of -- specific subheading

dpi DPI, see Public Instruction, Department of

drainage Drainage

Drainage districts [Admin.Code ATCP 48.01, 48.08, 48.12, 48.14, 48.20, 48.21, 48.28 (note)] - CR 18-052

Grants to county drainage boards [Admin.Code ATCP 48.60] - CR 19-055

drug abuse Drug abuse, see Drugs

drug testing Drug testing, see Alcohol and other drug abuse

drugs Drugs, see also Alcohol and other drug abuse; Drunken driving; Implied consent or alcohol concentration

4-Fluoroisobutyryl fentanyl added as a schedule I controlled substance [Admin.Code CSB 2.56] - CR 17-089

4-MePPP and a-PBP added as schedule I controlled substances [Admin.Code CSB 2.52] - CR 17-087

5F-ADB, 5F-AMB, ADB-FUBINACA, MDMB-CHMICA, and MDMB-FUBINACA added as schedule I controlled substances [Admin.Code CSB 2.55] - CR 17-088

5F-EDMB-PINACA, 5FMDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 added as schedule I controlled substances [Admin.Code CSB 2.66] - CR 20-048

AB-CHMINACA, AB-PINACA, and THJ-2201 added as schedule I controlled substances [Admin.Code CSB 2.50] - CR 17-085

Brexanolone and solriamfetol added as schedule I controlled substances [Admin.Code CSB 2.67] - CR 20-049

Cenobamate added as a schedule V controlled substance [Admin.Code CSB 2.73] - CR 20-075

Community substance abuse service standards: medical services for narcotic treatment service for opiate addiction [Admin.Code DHS 75.15] - CR 19-021

Continuing medical education for physicians re opioid prescribing guidelines [Admin.Code Med 13.02, 13.03] - CR 18-072

Exclusion of [123I] ioflupane as a schedule II controlled substance [Admin.Code CSB 2.40] - CR 16-060

FDA approved cannabidiol products added as a schedule V controlled substance [Admin.Code CSB 2.65] - CR 19-012

FDA approved cannabidiol removed from schedule V and excluding FDA approved cannabidiol from schedule I [Admin.Code CSB 2.75] - CR 20-077

Flualprazolam added as schedule IV controlled substance [Admin.Code CSB 2.77] - CR 20-079

FUB-AMB added as a schedule I controlled substance [Admin.Code CSB 2.60] - CR 18-022

Gabapentin: designating as a monitored drug having a substantial potential for abuse [Admin.Code CSB 4.03] - CR 20-080

Hazardous waste, universal waste, pharmaceuticals, and used oil: generation, transportation, recycling, treatment, storage, and disposal changes; and affecting small business [Admin.Code NR 149.13 Table 2, 211.10, 211.17, 502.09, 506.095, 660.02, 660.04, 660.05, 660.10, 660.11, 660.20, 660.30, 660.31, 660.33, 660.34, 660.40, 660.41, 660.42, 660.43, 661, 661 Appendices I, VII, and VIII, 662, 663.10, 663.10 subch. A (note), 663.12, 663.20, 663.21, 663.25, 664.0001, 664.0004, 664.0012, 664.0015, 664.0052, 664.0056, 664.0071, 664.0072, 664.0101, 664.0112, 664.0143, 664.0170, 664.0174 (note), 664.0178 (note), 664.0191, 664.0193, 664.0196 (note), 664.0197, 664.0198, 664.0221, 664.0228, 664.0229, 664.0256, 664.0258, 664.0301, 664.0312, 664.0316, 664.0340, 664.0351 (note), 664.0551, 664.0552, 664.0553, 664.0554, 664.1030, 664.1050, 664.1057, 664.1064, 664.1086, 664.1101, 664.1102, 664.1200 (note), 664.1202, 665.0001, 665.0012, 665.0020, 665.0052, 665.0056, 665.0071, 665.0072, 665.0090, 665.0112, 665.0118, 665.0143, 665.0174 (note), 665.0193, 665.0195, 665.0196 (note 1), 665.0197, 665.0198, 665.0221, 665.0228, 665.0229, 665.0256, 665.0258, 665.0301, 665.0312, 665.0316, 665.0340, 665.0351 (note), 665.0381 (note), 665.0404 (note), 665.0405, 665.0440, 665.1030, 665.1050, 665.1057, 665.1063, 665.1064, 665.1087, 665.1088, 665.1101, 665.1102, 665.1202, 666.020, 666.022, 666.023 (2) (note), 666.070, 666.080, 666.100, 666.101, 666.103, 666.108, 666.112, 666.202, 666.210, 666.220, 666.255, 666.305, 666.901, 666.903, 666 [Appendices], 666 subch. P, 667.0003, 667.0071, 667.0147, 667.0201, 667.0202, 667.1108, 668.01, 668.07, 668.31, 668.37, 668.38, 668.39, 668.40, 668.40 Table, 668.45, 668.48 Table and table note 6, 668.50, 668 Appendix VI, 670.001, 670.002, 670.014, 670.019, 670.042, 670.062, 670.066, 670.320, 670.432, 670 Appendices I and II, 673.03, 673.05, 673.08, 673.13, 673.20, 673.33, 673.39, 673.40, 673.56, 673.60, 673.62, 673.70, 673.80, 679.01, 679.10, 679.11 Table 1 table note 2, 679.40] - CR 19-082

Isotonitazene and 1P-LSD added as a schedule I controlled substance [Admin.Code CSB 2.72] - CR 20-023

Lasmiditan added as a schedule V controlled substance [Admin.Code CSB 2.71] - CR 20-058

Lemborexant added as a schedule IV controlled substance [Admin.Code CSB 2.74] - CR 20-076

MAB-CHMINACA added as a schedule I controlled substance [Admin.Code CSB 2.51] - CR 17-086

Medicaid-covered services [Admin.Code DHS 107.03, 107.10] - CR 20-063

MMB-FUBICA and 4F-MDMB-BINACA added as a schedule I controlled substance [Admin.Code CSB 2.70] - CR 20-022

MT-45 added as a schedule I controlled substance [Admin.Code CSB 2.61] - CR 18-069

N-Ethylhexedrone, aPHP, 4-MEAP, MPHP, PV8 and 4-chloro-a-PVP added as schedule I controlled substances [Admin.Code CSB 2.68] - CR 20-050

N-ethylpentylone added as a schedule I controlled substance [Admin.Code CSB 2.64] - CR 19-011

Naldemedine excluded as a controlled substance [Admin.Code CSB 2.58] - CR 18-024

Norfentanyl added as a schedule II controlled substance [Admin.Code CSB 2.76] - CR 20-078

Noroxymorphone added as a schedule II controlled substance [Admin.Code CSB 2.69] - CR 20-051

Operation of prescription drug monitoring program [Admin.Code CSB 4.04, 4.09, 4.093, 4.11] - CR 19-156

Oral solutions containing dronabinol added as schedule II controlled substance [Admin.Code CSB 2.54] - CR 18-055

Ortho-fluorofentanyl added as a schedule I controlled substance [Admin.Code CSB 2.59] - CR 18-023

Para-chloroisobutyryl fentanyl added as a schedule I controlled substance [Admin.Code CSB 2.62] - CR 18-070

Scheduling furanyl fentanyl as a controlled substance [Admin.Code CSB 2.42] - CR 16-059

Storage of drugs and controlled substances [Admin.Code Phar 6.07, 6.075] - CR 19-165

drugs _ criminal acts and law enforcement Drugs — Criminal acts and law enforcement

NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA, and 5F-CUMYL-P7AICA added as schedule I controlled substances [Admin.Code CSB 2.63] - CR 19-010

drunken driving Drunken driving, see also Implied consent or alcohol concentration

Frequent sobriety testing pilot program: standards and procedures [Admin.Code Jus 19] - CR 18-068

dsps DSPS, see Safety and Professional Services, Department of

dva DVA, see Veterans Affairs, Department of

dwd DWD, see Workforce Development, Department of

dwelling or dwelling code Dwelling or dwelling code, see Housing

E E

eab EAB, see Educational Approval Board

education Education, see Colleges and universities; Scholarships and loans; School, and its subheadings; University of Wisconsin

educational approval board Educational Approval Board

Educational approval program: revisions re 2017 WisAct 59 elimination of EAB [Admin.Code SPS 401.01, 404 (note 2), 404.01, 404.07, 404.10, 407.04] - CR 20-004

edvest _college savings program_ EdVest (college savings program), see Scholarships and loans

elderly Elderly, see Senior citizen

elections _ campaign expense Elections — Campaign expense